United States Biotechnology & Medical Research

Precision BioSciences Inc (DTIL)

Track

Track

Precision BioSciences witnessed two insider purchases totaling approximately 23,500 USD during late September 2026. These acquisitions occurred following an August earnings report that showed a slight beat. Despite a 20.8% decline in share value over the past quarter, these recent transactions represent the only notable activity within the last ninety days.
Ticker: DTIL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Precision BioSciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Frankel Stanley Non-Executive Director
Transaction date
Purchase
Price
274.46
Quantity 7,114 +18.4%
Value US$4,288,026
2.9
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
329.07
Quantity 16,372 +5.5%
Value US$1,047,179
3.5
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
101.00
Quantity 51,317 +20.4%
Value US$662,683
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
3.84
Quantity 4,925 -3.9%
Value US$18,912
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
3.84
Quantity 20,559 -7.8%
Value US$78,947
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.84
Quantity 8,149 -6.1%
Value US$31,292
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
3.84
Quantity 4,925 -8.0%
Value US$18,912
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 4,925
Value US$18,929
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 4,925
Value US$18,929
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.84
Quantity 20,559
Value US$79,019
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 8,149
Value US$31,321
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.17
Quantity 34,799
Value US$145,202
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
4.17
Quantity 34,799 -15.1%
Value US$145,112
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
4.03
Quantity 15,213 -12.5%
Value US$61,308
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
4.03
Quantity 10,200 -8.5%
Value US$41,106
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
4.03
Quantity 8,854 -16.5%
Value US$35,682
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 8,854
Value US$35,653
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 10,200
Value US$41,073
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 15,213
Value US$61,260
2.9
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
4.72
Quantity 3,000 +14.4%
Value US$14,160
2.9
Frankel Stanley Non-Executive Director
Transaction date
Purchase
Price
4.70
Quantity 2,700 +16.1%
Value US$12,690
3.5
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.97
Quantity 1,381 +6.3%
Value US$6,864
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
6.49
Quantity 665 -2.3%
Value US$4,316
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
6.49
Quantity 3,409 -2.9%
Value US$22,124
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.49
Quantity 1,303 -1.7%
Value US$8,456
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
6.49
Quantity 1,303
Value US$8,455
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.49
Quantity 3,409
Value US$22,121
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
6.49
Quantity 665
Value US$4,315
2.9
Frankel Stanley Non-Executive Director
Transaction date
Purchase
Price
4.97
Quantity 2,700 +19.2%
Value US$13,419
3.5
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.89
Quantity 1,400 +6.8%
Value US$6,846
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
4.26
Quantity 14,827 -16.8%
Value US$63,163
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
4.26
Quantity 14,827
Value US$63,208
3.5
Buehler Kevin Non-Executive Director
Transaction date
Purchase
Price
4.16
Quantity 5,076 +22.0%
Value US$21,116
3.5
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.14
Quantity 1,682 +8.9%
Value US$6,963
3.5
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.75
Quantity 1,839 +25.5%
Value US$8,735
3.5
Buehler Kevin Non-Executive Director
Transaction date
Purchase
Price
4.67
Quantity 4,523 +51.9%
Value US$21,122
2.9
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
5.30
Quantity 3,250 +41.6%
Value US$17,225
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
5.56
Quantity 964 -0.9%
Value US$5,360
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.56
Quantity 964
Value US$5,355
List Alan Officer Officer
Transaction date
Proposed sale
Price
5.06
Quantity 333
Value US$1,684
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
4.91
Quantity 154 -0.2%
Value US$756
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
4.91
Quantity 272 -1.1%
Value US$1,336
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
4.91
Quantity 154
Value US$756
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
4.91
Quantity 272
Value US$1,336
List Alan Officer Officer
Transaction date
Proposed sale
Price
5.04
Quantity 672
Value US$3,387
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
4.79
Quantity 8,928
Value US$42,727
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
4.79
Quantity 10,287
Value US$49,230
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
4.79
Quantity 8,928 -26.8%
Value US$42,765
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
4.79
Quantity 10,287 -10.5%
Value US$49,275
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
4.67
Quantity 36,838 -25.6%
Value US$172,033
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.67
Quantity 36,838
Value US$172,162
2.9
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
4.49
Quantity 3,605 +85.8%
Value US$16,186
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Purchase
Price
4.75
Quantity 2,113 +5.5%
Value US$10,037
3.5
Buehler Kevin Non-Executive Director
Transaction date
Purchase
Price
4.88
Quantity 4,320 +98.4%
Value US$21,082
3.5
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.55
Quantity 3,016 +71.8%
Value US$13,723
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Purchase
Price
6.76
Quantity 3,000 +8.6%
Value US$20,280
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Sale
Price
8.19
Quantity 3,012 -9.5%
Value US$24,668
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
8.19
Quantity 588 -6.9%
Value US$4,816
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
8.19
Quantity 588
Value US$4,816
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.19
Quantity 3,012
Value US$24,669
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
11.79
Quantity 93 -1.4%
Value US$1,096
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Sale
Price
11.79
Quantity 50 -0.1%
Value US$590
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
11.79
Quantity 93
Value US$1,096
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
11.79
Quantity 50
Value US$589
List Alan Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.32
Quantity 290 -6.1%
Value US$2,993
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
10.32
Quantity 272 -4.6%
Value US$2,807
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
10.32
Quantity 272 -4.6%
Value US$2,807
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
10.32
Quantity 1,526 -10.0%
Value US$15,748
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Sale
Price
10.32
Quantity 154 -0.2%
Value US$1,589
List Alan Officer Officer
Transaction date
Proposed sale
Price
10.32
Quantity 290
Value US$2,993
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
10.32
Quantity 272
Value US$2,807
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
10.32
Quantity 154
Value US$1,590
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
10.32
Quantity 1,526
Value US$15,750
List Alan Officer Officer
Transaction date
Proposed sale
Price
10.03
Quantity 238
Value US$2,386
List Alan Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.03
Quantity 238 -5.9%
Value US$2,386
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-30 2026-09-28 B Purchase
2.9
Frankel Stanley
Non-Executive Director
7,114 +18.4%
274.46
US$4,288,026 		7,114 +18.4% 274.46 US$4,288,026
2026-09-29 2026-09-25 B Purchase
2.9
Germano Geno J
Non-Executive Director
16,372 +5.5%
329.07
US$1,047,179 		16,372 +5.5% 329.07 US$1,047,179
2026-09-29 2026-09-25 B Purchase
3.5
Brown Melinda
Non-Executive Director
51,317 +20.4%
101.00
US$662,683 		51,317 +20.4% 101.00 US$662,683
2026-02-19 2026-02-18 PlS Planned sale
2.3
SMITH J. JEFFERSON

Chief Research Officer

Officer
4,925 -3.9%
3.84
US$18,912 		4,925 -3.9% 3.84 US$18,912
2026-02-19 2026-02-18 PlS Planned sale
3.4
Amoroso Michael

President and CEO

Executive Director
20,559 -7.8%
3.84
US$78,947 		20,559 -7.8% 3.84 US$78,947
2026-02-19 2026-02-18 PlS Planned sale
2.1
Kelly John Alexander

Chief Financial Officer

Officer
8,149 -6.1%
3.84
US$31,292 		8,149 -6.1% 3.84 US$31,292
2026-02-19 2026-02-18 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
4,925 -8.0%
3.84
US$18,912 		4,925 -8.0% 3.84 US$18,912
2026-02-18 2026-02-18 PrS Proposed sale
2.3
SMITH J. JEFFERSON

Officer

Officer
4,925
3.84
US$18,929 		4,925 3.84 US$18,929
2026-02-18 2026-02-18 PrS Proposed sale
Scimeca Dario

Officer

Officer
4,925
3.84
US$18,929 		4,925 3.84 US$18,929
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
20,559
3.84
US$79,019 		20,559 3.84 US$79,019
2026-02-18 2026-02-18 PrS Proposed sale
2.1
Kelly John Alexander

Officer

Officer
8,149
3.84
US$31,321 		8,149 3.84 US$31,321
2026-01-22 2026-01-22 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
34,799
4.17
US$145,202 		34,799 4.17 US$145,202
2026-01-22 2026-01-22 PlS Planned sale
3.4
Amoroso Michael

President and CEO

Executive Director
34,799 -15.1%
4.17
US$145,112 		34,799 -15.1% 4.17 US$145,112
2026-01-22 2026-01-21 PlS Planned sale
2.1
Kelly John Alexander

Chief Financial Officer

Officer
15,213 -12.5%
4.03
US$61,308 		15,213 -12.5% 4.03 US$61,308
2026-01-22 2026-01-21 PlS Planned sale
2.3
SMITH J. JEFFERSON

Chief Research Officer

Officer
10,200 -8.5%
4.03
US$41,106 		10,200 -8.5% 4.03 US$41,106
2026-01-22 2026-01-21 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
8,854 -16.5%
4.03
US$35,682 		8,854 -16.5% 4.03 US$35,682
2026-01-21 2026-01-21 PrS Proposed sale
Scimeca Dario

Officer

Officer
8,854
4.03
US$35,653 		8,854 4.03 US$35,653
2026-01-21 2026-01-21 PrS Proposed sale
2.3
SMITH J. JEFFERSON

Officer

Officer
10,200
4.03
US$41,073 		10,200 4.03 US$41,073
2026-01-21 2026-01-21 PrS Proposed sale
2.1
Kelly John Alexander

Officer

Officer
15,213
4.03
US$61,260 		15,213 4.03 US$61,260
2025-12-17 2025-12-16 B Purchase
2.9
Germano Geno J
Non-Executive Director
3,000 +14.4%
4.72
US$14,160 		3,000 +14.4% 4.72 US$14,160
2025-12-17 2025-12-16 B Purchase
2.9
Frankel Stanley
Non-Executive Director
2,700 +16.1%
4.70
US$12,690 		2,700 +16.1% 4.70 US$12,690
2025-12-17 2025-12-15 B Purchase
3.5
Brown Melinda
Non-Executive Director
1,381 +6.3%
4.97
US$6,864 		1,381 +6.3% 4.97 US$6,864
2025-11-04 2025-11-03 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
665 -2.3%
6.49
US$4,316 		665 -2.3% 6.49 US$4,316
2025-11-04 2025-11-03 PlS Planned sale
3.4
Amoroso Michael

President and CEO

Executive Director
3,409 -2.9%
6.49
US$22,124 		3,409 -2.9% 6.49 US$22,124
2025-11-04 2025-11-03 PlS Planned sale
2.1
Kelly John Alexander

Chief Financial Officer

Officer
1,303 -1.7%
6.49
US$8,456 		1,303 -1.7% 6.49 US$8,456
2025-11-03 2025-11-03 PrS Proposed sale
2.1
Kelly John Alexander

Officer

Officer
1,303
6.49
US$8,455 		1,303 6.49 US$8,455
2025-11-03 2025-11-03 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
3,409
6.49
US$22,121 		3,409 6.49 US$22,121
2025-11-03 2025-11-03 PrS Proposed sale
Scimeca Dario

Officer

Officer
665
6.49
US$4,315 		665 6.49 US$4,315
2025-09-30 2025-09-26 B Purchase
2.9
Frankel Stanley
Non-Executive Director
2,700 +19.2%
4.97
US$13,419 		2,700 +19.2% 4.97 US$13,419
2025-09-24 2025-09-22 B Purchase
3.5
Brown Melinda
Non-Executive Director
1,400 +6.8%
4.89
US$6,846 		1,400 +6.8% 4.89 US$6,846
2025-07-08 2025-07-03 PlS Planned sale
2.1
Kelly John Alexander

Chief Financial Officer

Officer
14,827 -16.8%
4.26
US$63,163 		14,827 -16.8% 4.26 US$63,163
2025-07-03 2025-07-03 PrS Proposed sale
2.1
Kelly John Alexander

Officer

Officer
14,827
4.26
US$63,208 		14,827 4.26 US$63,208
2025-06-27 2025-06-25 B Purchase
3.5
Buehler Kevin
Non-Executive Director
5,076 +22.0%
4.16
US$21,116 		5,076 +22.0% 4.16 US$21,116
2025-06-27 2025-06-25 B Purchase
3.5
Brown Melinda
Non-Executive Director
1,682 +8.9%
4.14
US$6,963 		1,682 +8.9% 4.14 US$6,963
2025-03-28 2025-03-26 B Purchase
3.5
Brown Melinda
Non-Executive Director
1,839 +25.5%
4.75
US$8,735 		1,839 +25.5% 4.75 US$8,735
2025-03-28 2025-03-26 B Purchase
3.5
Buehler Kevin
Non-Executive Director
4,523 +51.9%
4.67
US$21,122 		4,523 +51.9% 4.67 US$21,122
2025-03-27 2025-03-25 B Purchase
2.9
Germano Geno J
Non-Executive Director
3,250 +41.6%
5.30
US$17,225 		3,250 +41.6% 5.30 US$17,225
2025-03-25 2025-03-24 PlS Planned sale
3.4
Amoroso Michael

President and CEO

Executive Director
964 -0.9%
5.56
US$5,360 		964 -0.9% 5.56 US$5,360
2025-03-24 2025-03-24 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
964
5.56
US$5,355 		964 5.56 US$5,355
2025-03-05 2025-03-05 PrS Proposed sale
List Alan

Officer

Officer
333
5.06
US$1,684 		333 5.06 US$1,684
2025-03-05 2025-03-04 PlS Planned sale
2.3
SMITH J. JEFFERSON

Chief Research Officer

Officer
154 -0.2%
4.91
US$756 		154 -0.2% 4.91 US$756
2025-03-05 2025-03-04 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
272 -1.1%
4.91
US$1,336 		272 -1.1% 4.91 US$1,336
2025-03-04 2025-03-04 PrS Proposed sale
2.3
SMITH J. JEFFERSON

Officer

Officer
154
4.91
US$756 		154 4.91 US$756
2025-03-04 2025-03-04 PrS Proposed sale
Scimeca Dario

Officer

Officer
272
4.91
US$1,336 		272 4.91 US$1,336
2025-01-24 2025-01-24 PrS Proposed sale
List Alan

Officer

Officer
672
5.04
US$3,387 		672 5.04 US$3,387
2025-01-22 2025-01-22 PrS Proposed sale
Scimeca Dario

Officer

Officer
8,928
4.79
US$42,727 		8,928 4.79 US$42,727
2025-01-22 2025-01-22 PrS Proposed sale
2.3
SMITH J. JEFFERSON

Officer

Officer
10,287
4.79
US$49,230 		10,287 4.79 US$49,230
2025-01-22 2025-01-22 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
8,928 -26.8%
4.79
US$42,765 		8,928 -26.8% 4.79 US$42,765
2025-01-22 2025-01-22 PlS Planned sale
2.3
SMITH J. JEFFERSON

Chief Research Officer

Officer
10,287 -10.5%
4.79
US$49,275 		10,287 -10.5% 4.79 US$49,275
2025-01-22 2025-01-21 PlS Planned sale
3.4
Amoroso Michael

President and CEO

Executive Director
36,838 -25.6%
4.67
US$172,033 		36,838 -25.6% 4.67 US$172,033
2025-01-21 2025-01-21 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
36,838
4.67
US$172,162 		36,838 4.67 US$172,162
2025-01-02 2024-12-30 B Purchase
2.9
Germano Geno J
Non-Executive Director
3,605 +85.8%
4.49
US$16,186 		3,605 +85.8% 4.49 US$16,186
2024-12-31 2024-12-27 B Purchase
2.1
Kelly John Alexander

Chief Financial Officer

Officer
2,113 +5.5%
4.75
US$10,037 		2,113 +5.5% 4.75 US$10,037
2024-12-31 2024-12-27 B Purchase
3.5
Buehler Kevin
Non-Executive Director
4,320 +98.4%
4.88
US$21,082 		4,320 +98.4% 4.88 US$21,082
2024-12-30 2024-12-26 B Purchase
3.5
Brown Melinda
Non-Executive Director
3,016 +71.8%
4.55
US$13,723 		3,016 +71.8% 4.55 US$13,723
2024-11-21 2024-11-21 B Purchase
2.1
Kelly John Alexander

Chief Financial Officer

Officer
3,000 +8.6%
6.76
US$20,280 		3,000 +8.6% 6.76 US$20,280
2024-11-05 2024-11-04 S Sale
3.4
Amoroso Michael

President and CEO

Executive Director
3,012 -9.5%
8.19
US$24,668 		3,012 -9.5% 8.19 US$24,668
2024-11-05 2024-11-04 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
588 -6.9%
8.19
US$4,816 		588 -6.9% 8.19 US$4,816
2024-11-04 2024-11-04 PrS Proposed sale
Scimeca Dario

Officer

Officer
588
8.19
US$4,816 		588 8.19 US$4,816
2024-11-04 2024-11-04 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
3,012
8.19
US$24,669 		3,012 8.19 US$24,669
2024-06-11 2024-06-10 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
93 -1.4%
11.79
US$1,096 		93 -1.4% 11.79 US$1,096
2024-06-11 2024-06-10 S Sale
2.3
SMITH J. JEFFERSON

Chief Research Officer

Officer
50 -0.1%
11.79
US$590 		50 -0.1% 11.79 US$590
2024-06-10 2024-06-10 PrS Proposed sale
Scimeca Dario

Officer

Officer
93
11.79
US$1,096 		93 11.79 US$1,096
2024-06-10 2024-06-10 PrS Proposed sale
2.3
SMITH J. JEFFERSON

Officer

Officer
50
11.79
US$589 		50 11.79 US$589
2024-05-03 2024-05-02 PlS Planned sale
List Alan

Chief Medical Officer

Officer
290 -6.1%
10.32
US$2,993 		290 -6.1% 10.32 US$2,993
2024-05-03 2024-05-02 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
272 -4.6%
10.32
US$2,807 		272 -4.6% 10.32 US$2,807
2024-05-03 2024-05-02 PlS Planned sale
Scimeca Dario

General Counsel and Secretary

Officer
272 -4.6%
10.32
US$2,807 		272 -4.6% 10.32 US$2,807
2024-05-03 2024-05-02 PlS Planned sale
3.4
Amoroso Michael

President and CEO

Executive Director
1,526 -10.0%
10.32
US$15,748 		1,526 -10.0% 10.32 US$15,748
2024-05-03 2024-05-02 S Sale
2.3
SMITH J. JEFFERSON

Chief Research Officer

Officer
154 -0.2%
10.32
US$1,589 		154 -0.2% 10.32 US$1,589
2024-05-02 2024-05-02 PrS Proposed sale
List Alan

Officer

Officer
290
10.32
US$2,993 		290 10.32 US$2,993
2024-05-02 2024-05-02 PrS Proposed sale
Scimeca Dario

Officer

Officer
272
10.32
US$2,807 		272 10.32 US$2,807
2024-05-02 2024-05-02 PrS Proposed sale
2.3
SMITH J. JEFFERSON

Officer

Officer
154
10.32
US$1,590 		154 10.32 US$1,590
2024-05-02 2024-05-02 PrS Proposed sale
3.4
Amoroso Michael

Officer; Director

Executive Director
1,526
10.32
US$15,750 		1,526 10.32 US$15,750
2024-04-30 2024-04-30 PrS Proposed sale
List Alan

Officer

Officer
238
10.03
US$2,386 		238 10.03 US$2,386
2024-04-30 2024-04-30 PlS Planned sale
List Alan

Chief Medical Officer

Officer
238 -5.9%
10.03
US$2,386 		238 -5.9% 10.03 US$2,386
Explore more

More insider trading research around Precision BioSciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America